HEADER GLYCOPROTEIN/PEPTIDE 29-NOV-05 2C7U TITLE CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR TITLE 2 CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN; COMPND 3 CHAIN: A, D; COMPND 4 SYNONYM: HLA-A2, MHC CLASS I ANTIGEN A*2; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 8 CHAIN: B, E; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: GAG PROTEIN; COMPND 12 CHAIN: C, F; COMPND 13 FRAGMENT: RESIDUES 7-15 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BLR; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-22B; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: BLR; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET-22B; SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 20 ORGANISM_TAXID: 11676 KEYWDS GLYCOPROTEIN-PEPTIDE COMPLEX, MHC, TCR, HLA-A2, HIV, GLYCOPROTEIN, KEYWDS 2 IMMUNE RESPONSE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, KEYWDS 3 PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN/PEPTIDE COMPLEX, AIDS EXPDTA X-RAY DIFFRACTION AUTHOR A.K.IVERSEN,G.STEWART-JONES,G.H.LEARN,N.CHRISTIE,C.SYLVESTER-HVIID, AUTHOR 2 A.E.ARMITAGE,R.KAUL,T.BEATTIE,J.K.LEE,Y.LI,P.CHOTIYARNWONG,T.DONG, AUTHOR 3 X.XU,M.A.LUSCHER,K.MACDONALD,H.ULLUM,B.KLARLUND-PEDERSEN,P.SKINHOJ, AUTHOR 4 J.L.FUGGER,S.BUUS,J.I.MULLINS,E.Y.JONES,P.A.VAN DER MERWE, AUTHOR 5 A.J.MCMICHAEL REVDAT 3 13-JUL-11 2C7U 1 VERSN REVDAT 2 24-FEB-09 2C7U 1 VERSN REVDAT 1 08-MAR-06 2C7U 0 JRNL AUTH A.K.IVERSEN,G.STEWART-JONES,G.H.LEARN,N.CHRISTIE, JRNL AUTH 2 C.SYLVESTER-HVIID,A.E.ARMITAGE,R.KAUL,T.BEATTIE,J.K.LEE, JRNL AUTH 3 Y.LI,P.CHOTIYARNWONG,T.DONG,X.XU,M.A.LUSCHER,K.MACDONALD, JRNL AUTH 4 H.ULLUM,B.KLARLUND-PEDERSEN,P.SKINHOJ,L.FUGGER,S.BUUS, JRNL AUTH 5 J.I.MULLINS,E.Y.JONES,P.A.VAN DER MERWE,A.J.MCMICHAEL JRNL TITL CONFLICTING SELECTIVE FORCES AFFECT T CELL RECEPTOR JRNL TITL 2 CONTACTS IN AN IMMUNODOMINANT HUMAN IMMUNODEFICIENCY VIRUS JRNL TITL 3 EPITOPE. JRNL REF NAT.IMMUNOL. V. 7 179 2006 JRNL REFN ISSN 1529-2908 JRNL PMID 16388312 JRNL DOI 10.1038/NI1298 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 35178 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.251 REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.314 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1851 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2019 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3420 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.4500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6300 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 219 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.60000 REMARK 3 B22 (A**2) : 1.58000 REMARK 3 B33 (A**2) : 1.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.34000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.513 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.331 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.326 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 26.462 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6482 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8794 ; 1.280 ; 1.920 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 762 ; 6.385 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 348 ;33.353 ;23.161 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1056 ;17.935 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 56 ;19.197 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 900 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5080 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2641 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4160 ; 0.292 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 307 ; 0.194 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 22 ; 0.178 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.156 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3949 ; 0.462 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6156 ; 0.799 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2986 ; 1.121 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2638 ; 1.705 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 180 REMARK 3 ORIGIN FOR THE GROUP (A): 29.3890 48.6960 68.5240 REMARK 3 T TENSOR REMARK 3 T11: 0.0013 T22: 0.1734 REMARK 3 T33: 0.0722 T12: 0.2016 REMARK 3 T13: 0.2977 T23: 0.4785 REMARK 3 L TENSOR REMARK 3 L11: 3.0331 L22: 3.4393 REMARK 3 L33: 5.5274 L12: -0.3568 REMARK 3 L13: 1.9200 L23: -0.2124 REMARK 3 S TENSOR REMARK 3 S11: -0.1821 S12: -0.0931 S13: -0.1002 REMARK 3 S21: 0.4402 S22: 0.5978 S23: 1.0341 REMARK 3 S31: -0.5098 S32: -0.4387 S33: -0.4157 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 181 A 275 REMARK 3 ORIGIN FOR THE GROUP (A): 61.0430 53.2250 52.7420 REMARK 3 T TENSOR REMARK 3 T11: -0.2534 T22: -0.2781 REMARK 3 T33: -0.0563 T12: -0.0108 REMARK 3 T13: 0.0486 T23: 0.1808 REMARK 3 L TENSOR REMARK 3 L11: 7.7635 L22: 5.8468 REMARK 3 L33: 16.0825 L12: 1.6840 REMARK 3 L13: -6.7332 L23: -6.5883 REMARK 3 S TENSOR REMARK 3 S11: 0.5297 S12: 0.1690 S13: 0.9008 REMARK 3 S21: 0.2207 S22: -0.4038 S23: -0.7697 REMARK 3 S31: -1.0758 S32: 0.4563 S33: -0.1259 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 99 REMARK 3 ORIGIN FOR THE GROUP (A): 50.7140 34.5350 59.9490 REMARK 3 T TENSOR REMARK 3 T11: -0.3154 T22: -0.3000 REMARK 3 T33: -0.4101 T12: -0.0607 REMARK 3 T13: -0.0493 T23: 0.1237 REMARK 3 L TENSOR REMARK 3 L11: 6.9619 L22: 5.9532 REMARK 3 L33: 3.9789 L12: -1.0663 REMARK 3 L13: 1.4085 L23: -1.4163 REMARK 3 S TENSOR REMARK 3 S11: -0.0127 S12: 0.1668 S13: -0.3635 REMARK 3 S21: -0.0339 S22: 0.4078 S23: 0.2106 REMARK 3 S31: 0.0661 S32: -0.1059 S33: -0.3951 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 1 D 180 REMARK 3 ORIGIN FOR THE GROUP (A): 60.9610 41.4840 94.5200 REMARK 3 T TENSOR REMARK 3 T11: 0.0622 T22: 0.1703 REMARK 3 T33: 0.1188 T12: -0.2701 REMARK 3 T13: -0.2762 T23: 0.5470 REMARK 3 L TENSOR REMARK 3 L11: 2.7584 L22: 3.6325 REMARK 3 L33: 5.6652 L12: 0.1839 REMARK 3 L13: -1.9440 L23: 0.0388 REMARK 3 S TENSOR REMARK 3 S11: -0.1327 S12: 0.1853 S13: 0.1143 REMARK 3 S21: -0.3137 S22: 0.6436 S23: 0.9628 REMARK 3 S31: 0.5254 S32: -0.5578 S33: -0.5109 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 181 D 275 REMARK 3 ORIGIN FOR THE GROUP (A): 92.6490 36.9230 110.2990 REMARK 3 T TENSOR REMARK 3 T11: -0.2328 T22: -0.3255 REMARK 3 T33: -0.0649 T12: -0.0097 REMARK 3 T13: -0.0733 T23: 0.1795 REMARK 3 L TENSOR REMARK 3 L11: 9.3836 L22: 5.9706 REMARK 3 L33: 17.1860 L12: -1.5381 REMARK 3 L13: 7.6474 L23: -5.8806 REMARK 3 S TENSOR REMARK 3 S11: 0.5383 S12: -0.1851 S13: -0.9421 REMARK 3 S21: -0.1797 S22: -0.3489 S23: -0.7833 REMARK 3 S31: 1.2052 S32: 0.5646 S33: -0.1895 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 0 E 99 REMARK 3 ORIGIN FOR THE GROUP (A): 82.2670 55.6250 103.0310 REMARK 3 T TENSOR REMARK 3 T11: -0.3069 T22: -0.2859 REMARK 3 T33: -0.4190 T12: 0.0558 REMARK 3 T13: 0.0307 T23: 0.1251 REMARK 3 L TENSOR REMARK 3 L11: 6.8200 L22: 6.3066 REMARK 3 L33: 3.6786 L12: 0.9623 REMARK 3 L13: -1.1748 L23: -1.4474 REMARK 3 S TENSOR REMARK 3 S11: -0.0293 S12: -0.2338 S13: 0.3799 REMARK 3 S21: -0.0011 S22: 0.4300 S23: 0.2503 REMARK 3 S31: -0.0052 S32: -0.0961 S33: -0.4007 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2C7U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-NOV-05. REMARK 100 THE PDBE ID CODE IS EBI-26544. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.977 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 138420 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.900 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA):NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.92700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 INVOLVED IN THE PRESENTATION OF FOREIGN ANTIGENS TO THE REMARK 400 IMMUNE SYSTEM REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 276 REMARK 465 PRO D 276 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU D 81 O HOH D 2028 2.14 REMARK 500 OD1 ASP D 122 O HOH D 2041 2.16 REMARK 500 O GLY D 252 O HOH D 2067 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 58 CD GLU A 58 OE1 0.226 REMARK 500 GLU A 58 CD GLU A 58 OE2 0.198 REMARK 500 ASP A 220 CG ASP A 220 OD2 0.163 REMARK 500 LYS D 144 CD LYS D 144 CE 0.186 REMARK 500 ARG D 219 CD ARG D 219 NE 0.135 REMARK 500 ARG D 219 CZ ARG D 219 NH1 0.137 REMARK 500 ARG D 219 CZ ARG D 219 NH2 0.149 REMARK 500 ASP D 220 CG ASP D 220 OD1 0.177 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG D 219 NE - CZ - NH2 ANGL. DEV. = -6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -125.88 47.74 REMARK 500 ASN A 86 42.84 72.98 REMARK 500 PHE A 109 134.98 -38.18 REMARK 500 ASP A 119 34.53 70.23 REMARK 500 TYR A 123 -67.03 -128.14 REMARK 500 GLN A 180 43.25 -93.82 REMARK 500 HIS A 197 -30.32 -133.75 REMARK 500 LYS B 48 65.48 -106.35 REMARK 500 ASP B 98 45.49 -94.93 REMARK 500 ASN C 4 -86.60 -91.70 REMARK 500 ARG D 17 12.46 -152.99 REMARK 500 ASP D 29 -119.38 50.42 REMARK 500 SER D 88 150.57 -48.82 REMARK 500 TRP D 107 9.78 84.21 REMARK 500 LEU D 130 32.27 72.09 REMARK 500 PRO E 32 -176.52 -67.33 REMARK 500 LYS E 48 69.33 -100.29 REMARK 500 LEU E 54 106.08 -48.71 REMARK 500 GLU E 74 -47.00 -25.29 REMARK 500 ASP E 98 54.86 -112.73 REMARK 500 ASN F 4 -89.18 -94.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH REMARK 900 PEPTIDETYPDINQML FROM GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH REMARK 900 PEPTIDE VPLRPMTYFROM THE NEF PROTEIN REMARK 900 (75-82) OF HIV1 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH REMARK 900 PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA REMARK 900 PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE REMARK 900 BOUND TO HLA-B 3501 DUE TO NONSTANDARD REMARK 900 POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE REMARK 900 BOUND TO HLA-B 3501 DUE TO NONSTANDARD REMARK 900 POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I REMARK 900 GLYCOPROTEIN HLA-A2 ANDTHE T CELL CORECEPTOR CD8 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL REMARK 900 PEPTIDE (TAX), AND HLA-A 0201 REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II REMARK 900 HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) REMARK 900 COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC REMARK 900 (HLA-A2.1) COMPLEXED WITH BETA 2- REMARK 900 MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED REMARK 900 WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL REMARK 900 GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, REMARK 900 VIRAL PEPTIDE (TAX) AND MHC CLASS I REMARK 900 MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE REMARK 900 GAMMA/DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A REMARK 900 SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC REMARK 900 BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE REMARK 900 MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH REMARK 900 TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX REMARK 900 PEPTIDE COMPLEX REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA REMARK 900 0201) INCOMPLEX WITH A NONAMERIC PEPTIDE-A REMARK 900 FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 REMARK 900 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1 REMARK 900 (LPPVVAKEI) REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 REMARK 900 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2 REMARK 900 (TAFTIPSI) REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 REMARK 900 COMPLEXED TOPEPTIDE GP2 WITH THE SUBSTITUTION REMARK 900 (I2L/V5L/L9V) REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 REMARK 900 COMPLEXED TOGP2 PEPTIDE VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN REMARK 900 NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A REMARK 900 CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED REMARK 900 FC RECEPTOR REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA REMARK 900 -A 0201) COMPLEX WITH A NONAMERIC PEPTIDE REMARK 900 FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES REMARK 900 309-317) REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 REMARK 900 (HLA-A2, HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN REMARK 900 HLA-B(ASTERISK)2705 REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 REMARK 900 (LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC REMARK 900 (HLA-A2.1) COMPLEXED WITH BETA 2- REMARK 900 MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC REMARK 900 (HLA-A2.1) COMPLEXED WITH BETA 2- REMARK 900 MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- REMARK 900 PEPTIDE COMPLEX REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN REMARK 900 COMPLEX WITH PEPTIDE P1058 REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN REMARK 900 COMPLEX WITH PEPTIDE P1049-5V REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN REMARK 900 COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS REMARK 900 PROTEIN US2BOUND TO THE MHC CLASS I REMARK 900 MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL REMARK 900 KILLER CELLINHIBITORY RECEPTOR KIR2DL1 BOUND REMARK 900 TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN REMARK 900 COMPLEX WITH ADECAMERIC ALTERED PEPTIDE LIGAND REMARK 900 FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN REMARK 900 COMPLEX WITH ANONAMERIC ALTERED PEPTIDE LIGAND REMARK 900 (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA REMARK 900 2-MICROGLOBULIN REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR REMARK 900 HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR REMARK 900 HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 REMARK 900 -MICROGLOBULIN REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND REMARK 900 TO P1049/HLA-A2.1 REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR REMARK 900 VIRUS DETERMINANT REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX REMARK 900 WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR REMARK 900 HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN REMARK 900 COMPLEX WITH HLAB8-EBVPEPTIDE COMPLEX REMARK 900 RELATED ID: 1N2R RELATED DB: PDB REMARK 900 A NATURAL SELECTED DIMORPHISM IN HLA B*44 REMARK 900 ALTERS SELF,PEPTIDE REPORTOIRE AND T CELL REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED REMARK 900 WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE REMARK 900 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408) REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN REMARK 900 T-CELL RECEPTOR RECOGNITION. REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED REMARK 900 WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE REMARK 900 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408) REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH REMARK 900 A SULFATIDE REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, REMARK 900 A HOST ANDVIRAL MHC RECEPTOR REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS REMARK 900 FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH REMARK 900 IMMUNODOMINANT NONAMER AND DECAMER HIV-1 REMARK 900 EPITOPES CLEARLY REVEAL THEPRESENCE OF A REMARK 900 MIDDLE ANCHOR RESIDUE REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA REMARK 900 0201)COMPLEX WITH A NONAMERIC PEPTIDE-A REMARK 900 FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES REMARK 900 271-279) REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2) REMARK 900 TO HLA-A2.1 IS DUE TO A LACK OF REMARK 900 INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED REMARK 900 WITH HLA-A2 BOUND TO ALTERED HTLV-1 REMARK 900 TAX PEPTIDE P6A REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-Y8A REMARK 900 COMPLEXED WITH ALTERED HTLV-1 TAX REMARK 900 PEPTIDE V7R REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 REMARK 900 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH REMARK 900 IMMUNODOMINANT NONAMER AND DECAMER HIV-1 REMARK 900 EPITOPES CLEARLY REVEAL THEPRESENCE OF A REMARK 900 MIDDLE ANCHOR RESIDUE REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 REMARK 900 EPITOPE, SLLMWITQC,IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 REMARK 900 EPITOPE ANALOGUE,SLLMWITQA, IN COMPLEX WITH REMARK 900 HLA-A2 REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 REMARK 900 EPITOPE ANALOGUE,SLLMWITQS, IN COMPLEX WITH REMARK 900 HLA-A2 REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND REMARK 900 PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF REMARK 900 LIGAND EEFGRAYGF REMARK 900 RELATED ID: 1T1W RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF REMARK 900 HIV PEPTIDEVARIANTS BY CYTOTOXIC LYMPHOCYTE, REMARK 900 VARIANT SL9-3F6I8V REMARK 900 RELATED ID: 1T1X RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF REMARK 900 HIV PEPTIDEVARIANTS BY CYTOTOXIC LYMPHOCYTE, REMARK 900 VARIANT SL9-4L REMARK 900 RELATED ID: 1T1Y RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF REMARK 900 HIV PEPTIDEVARIANTS BY CYTOTOXIC LYMPHOCYTE, REMARK 900 VARIANT SL9-5V REMARK 900 RELATED ID: 1T1Z RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF REMARK 900 HIV PEPTIDEVARIANTS BY CYTOTOXIC LYMPHOCYTE, REMARK 900 VARIANT SL9-6A REMARK 900 RELATED ID: 1T20 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF REMARK 900 HIV PEPTIDEVARIANTS BY CYTOTOXIC LYMPHOCYTE, REMARK 900 VARIANT SL9-6I REMARK 900 RELATED ID: 1T21 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF REMARK 900 HIV PEPTIDEVARIANTS BY CYTOTOXIC LYMPHOCYTE, REMARK 900 VARIANT SL9, MONOCLINICCRYSTAL REMARK 900 RELATED ID: 1T22 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF REMARK 900 HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, REMARK 900 VARIANT SL9,ORTHORHOMBIC CRYSTAL REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY REMARK 900 ANTIGEN HLA-AW68 COMPLEXED WITH A DECAMERIC REMARK 900 PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100 REMARK 900 (209-217) BOUNDTO HUMAN CLASS I MHC HLA-A REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN REMARK 900 GP100(209-T2M) BOUND TO HUMAN CLASS I REMARK 900 MHC HLA-A2 REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A REMARK 900 BOUND BACTERIAL GLYCOLIPID REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING REMARK 900 LIGHT CHAIN SHUFFLING: A STRUCTURAL MODEL REMARK 900 FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED REMARK 900 WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE REMARK 900 (LMP2)OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED REMARK 900 WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE REMARK 900 (LMP2) OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR REMARK 900 HISTOCOMPATIBILITYCOMPLEX, H-2KD AT 2.0 A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED REMARK 900 WITH THE SELF-PEPTIDE TIS FROM EGF- REMARK 900 RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED REMARK 900 WITH THE SELF-PEPTIDE TIS FROM EGF- REMARK 900 RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN REMARK 900 COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS REMARK 900 NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF REMARK 900 14-MERICPEPTIDES IN COMPLEX WITH HLA-B* REMARK 900 3501 REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN REMARK 900 COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND REMARK 900 EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN REMARK 900 COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND REMARK 900 EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH REMARK 900 A SYNTHETIC MYCOBACTIN LIPOPEPTIDE REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS REMARK 900 IB MOLECULE M10.5 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING REMARK 900 AN 11-MER EBV ANTIGEN EPLPQGQLTAY REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH REMARK 900 AND WITHOUT ALPHA-GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX REMARK 900 WITH HLA-B*3508-13MER PEPTIDE REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE REMARK 900 BOUND TO HUMAN CLASS I MHC HLA-A2 WITH REMARK 900 THE E63Q AND K66A MUTATIONS IN THE HEAVY REMARK 900 CHAIN. REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE REMARK 900 BOUND TO HUMANCLASS I MHC HLA-A2 WITH REMARK 900 THE K66A MUTATION IN THE HEAVYCHAIN. REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED REMARK 900 IMMUNOGENICITY OF T CELL VACCINES REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED REMARK 900 IMMUNOGENICITY OF T CELL VACCINES REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF REMARK 900 THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED REMARK 900 TO HLA-B2705 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF REMARK 900 THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED REMARK 900 TO HLA-B2705 REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF REMARK 900 THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED REMARK 900 TO HLA-B2705 REMARK 900 RELATED ID: 2BSU RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL REMARK 900 CHANGES DURING TCR ENGAGEMENT REMARK 900 RELATED ID: 2BSV RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL REMARK 900 CHANGES DURING TCR ENGAGEMENT REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- REMARK 900 PEPTIDE COMPLEXES AND IDENTIFICATION OF REMARK 900 RELATED HLAS POTENTIALLY ASSOCIATED WITH REMARK 900 LONG-TERM NON-PROGRESSION REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A REMARK 900 0201) COMPLEXED WITH A DECAMERIC PEPTIDE REMARK 900 FROM CALRETICULIN REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1 REMARK 900 (HLA-A2.1 HUMAN LEUCOCYTE ANTIGEN) DBREF 2C7U A 1 276 UNP P01892 1A02_HUMAN 25 300 DBREF 2C7U B 0 0 PDB 2C7U 2C7U 0 0 DBREF 2C7U B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2C7U C 1 9 UNP O11822 O11822_9HIV1 7 15 DBREF 2C7U D 1 276 UNP P01892 1A02_HUMAN 25 300 DBREF 2C7U E 0 0 PDB 2C7U 2C7U 0 0 DBREF 2C7U E 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2C7U F 1 9 UNP O11822 O11822_9HIV1 7 15 SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 276 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 276 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 276 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 276 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 276 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 276 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 276 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 276 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 276 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 276 TRP GLU PRO SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 SER LEU PHE ASN THR ILE ALA VAL LEU SEQRES 1 D 276 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 D 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 D 276 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 D 276 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 D 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 D 276 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 D 276 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 D 276 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 D 276 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 D 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 D 276 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 D 276 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 D 276 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 D 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 D 276 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 D 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 D 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 D 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 D 276 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 D 276 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 D 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 D 276 TRP GLU PRO SEQRES 1 E 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 E 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 E 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 E 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 E 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 E 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 E 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 E 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 F 9 SER LEU PHE ASN THR ILE ALA VAL LEU FORMUL 7 HOH *219(H2 O) HELIX 1 1 GLY A 56 GLY A 83 1 28 HELIX 2 2 MET A 138 ALA A 150 1 13 HELIX 3 3 HIS A 151 GLY A 162 1 12 HELIX 4 4 GLY A 162 GLY A 175 1 14 HELIX 5 5 THR A 225 THR A 228 5 4 HELIX 6 6 GLN A 253 GLN A 255 5 3 HELIX 7 7 GLY D 56 TYR D 85 1 30 HELIX 8 8 ALA D 140 ALA D 150 1 11 HELIX 9 9 HIS D 151 GLY D 162 1 12 HELIX 10 10 GLY D 162 GLY D 175 1 14 HELIX 11 11 THR D 225 THR D 228 5 4 HELIX 12 12 GLY D 252 GLN D 255 5 4 SHEET 1 AA 7 GLU A 46 PRO A 47 0 SHEET 2 AA 7 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 7 ILE A 23 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 7 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 7 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 AA 7 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 7 LYS A 121 ASP A 122 -1 O LYS A 121 N TYR A 118 SHEET 1 AB 2 ILE A 124 LEU A 126 0 SHEET 2 AB 2 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AC 4 LYS A 186 HIS A 192 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 GLU A 229 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AD 4 LYS A 186 HIS A 192 0 SHEET 2 AD 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AD 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AD 4 ARG A 234 PRO A 235 -1 O ARG A 234 N GLN A 242 SHEET 1 AE 4 GLU A 222 ASP A 223 0 SHEET 2 AE 4 ILE A 213 ARG A 219 -1 O ARG A 219 N GLU A 222 SHEET 3 AE 4 TYR A 257 HIS A 263 -1 O THR A 258 N GLN A 218 SHEET 4 AE 4 LEU A 270 ARG A 273 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BA 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BB 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 BC 4 GLU B 44 ARG B 45 0 SHEET 2 BC 4 GLU B 36 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BC 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 BC 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 DA 8 GLU D 46 PRO D 47 0 SHEET 2 DA 8 THR D 31 ASP D 37 -1 O ARG D 35 N GLU D 46 SHEET 3 DA 8 ARG D 21 VAL D 28 -1 O ALA D 24 N PHE D 36 SHEET 4 DA 8 HIS D 3 VAL D 12 -1 O ARG D 6 N TYR D 27 SHEET 5 DA 8 THR D 94 VAL D 103 -1 O VAL D 95 N SER D 11 SHEET 6 DA 8 PHE D 109 TYR D 118 -1 N LEU D 110 O ASP D 102 SHEET 7 DA 8 LYS D 121 LEU D 126 -1 O LYS D 121 N TYR D 118 SHEET 8 DA 8 TRP D 133 ALA D 135 -1 O THR D 134 N ALA D 125 SHEET 1 DB 4 LYS D 186 ALA D 193 0 SHEET 2 DB 4 GLU D 198 PHE D 208 -1 O THR D 200 N HIS D 192 SHEET 3 DB 4 PHE D 241 PRO D 250 -1 O PHE D 241 N PHE D 208 SHEET 4 DB 4 GLU D 229 LEU D 230 -1 O GLU D 229 N ALA D 246 SHEET 1 DC 4 LYS D 186 ALA D 193 0 SHEET 2 DC 4 GLU D 198 PHE D 208 -1 O THR D 200 N HIS D 192 SHEET 3 DC 4 PHE D 241 PRO D 250 -1 O PHE D 241 N PHE D 208 SHEET 4 DC 4 ARG D 234 PRO D 235 -1 O ARG D 234 N GLN D 242 SHEET 1 DD 4 GLU D 222 ASP D 223 0 SHEET 2 DD 4 ILE D 213 ARG D 219 -1 O ARG D 219 N GLU D 222 SHEET 3 DD 4 TYR D 257 HIS D 263 -1 O THR D 258 N GLN D 218 SHEET 4 DD 4 LEU D 270 ARG D 273 -1 O LEU D 270 N VAL D 261 SHEET 1 EA 7 LYS E 6 SER E 11 0 SHEET 2 EA 7 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 EA 7 PHE E 62 PHE E 70 -1 O PHE E 62 N PHE E 30 SHEET 4 EA 7 GLU E 50 HIS E 51 -1 O GLU E 50 N TYR E 67 SHEET 5 EA 7 PHE E 62 PHE E 70 -1 O TYR E 67 N GLU E 50 SHEET 6 EA 7 SER E 55 PHE E 56 -1 O SER E 55 N TYR E 63 SHEET 7 EA 7 PHE E 62 PHE E 70 -1 O TYR E 63 N SER E 55 SHEET 1 EB 4 GLU E 44 ARG E 45 0 SHEET 2 EB 4 GLU E 36 LYS E 41 -1 O LYS E 41 N GLU E 44 SHEET 3 EB 4 TYR E 78 ASN E 83 -1 O ALA E 79 N LEU E 40 SHEET 4 EB 4 LYS E 91 LYS E 94 -1 O LYS E 91 N VAL E 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS D 101 CYS D 164 1555 1555 2.05 SSBOND 5 CYS D 203 CYS D 259 1555 1555 2.02 SSBOND 6 CYS E 25 CYS E 80 1555 1555 2.03 CISPEP 1 TYR A 209 PRO A 210 0 2.50 CISPEP 2 HIS B 31 PRO B 32 0 -5.74 CISPEP 3 TYR D 209 PRO D 210 0 4.91 CISPEP 4 HIS E 31 PRO E 32 0 -8.78 CRYST1 63.163 93.854 81.497 90.00 89.99 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015832 0.000000 -0.000003 0.00000 SCALE2 0.000000 0.010655 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012270 0.00000